NIAID Begins Trial of Zika Virus Vaccine
With homegrown Zika cases a reality in the United States, the National Institute of Allergy and Infectious Diseases (NIAID) has launched a clinical trial of an investigational vaccine.
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More